CASI Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Foresite Capital Fund VI, L.P. (“FCF VI”)(9.8%),Foresite Capital Management VI, LLC (“FCM VI”)(9.8%), etc.
CASI Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Foresite Capital Fund VI, L.P. (“FCF VI”)(9.8%),Foresite Capital Management VI, LLC (“FCM VI”)(9.8%), etc.
CASI製藥 | SC 13G：超過5%持股股東披露文件-Foresite Capital Fund VI, L.P. (“FCF VI”)(9.8%),Foresite Capital Management VI, LLC (“FCM VI”)(9.8%)等
資訊熱榜
更新時間